D-0356-2021 Class II Ongoing

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-0356-2021 was initiated by Teligent Pharma, Inc. on Apr 9, 2021 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: The recall status is ongoing. Affected quantity: 3432 tubes.

Recall details

Product Type
Drugs
Report Date
Apr 28, 2021
Initiation Date
Apr 9, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3432 tubes

Product description

Flurandrenolide Ointment USP, 0.05%, Net Wt. 60 grams, Rx Only, Teligent Pharma, Inc. Buena, New Jersey 08310 NDC 52565-017-60

Reason for recall

Failed Impurities/Degradation Specifications:

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot #13974 EXP 7/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0356-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0356-2021. Report a data issue: hello@regdatalab.com.